Effect of Filgotinib on Body Mass Index (BMI) and Effect of Baseline BMI on the Efficacy and Safety of Filgotinib in Rheumatoid Arthritis

Abstract Introduction This post hoc analysis of the phase 3 rheumatoid arthritis (RA) filgotinib clinical trial program assessed the effect of filgotinib on body mass index (BMI) in patients with RA and the impact of BMI on the efficacy and safety of filgotinib. Methods FINCH 1–3 were randomized, do...

全面介紹

書目詳細資料

Principais autores:	Alejandro Balsa, Siegfried Wassenberg, Yoshiya Tanaka, Anne Tournadre, Hans-Dieter Orzechowski, Vijay Rajendran, Udo Lendl, Pieter-Jan Stiers, Chris Watson, Roberto Caporali, James Galloway, Patrick Verschueren
格式:	Artigo
語言:	Inglês
出版:	Adis, Springer Healthcare 2023-09-01
叢編:	Rheumatology and Therapy
主題:	Body mass index Clinical trial DMARD Filgotinib Interventional study JAK inhibitor
在線閱讀:	https://doi.org/10.1007/s40744-023-00599-1
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!